Compounding Pharmacy · Franklin, TN · 503A
DCA Pharmacy Review
DCA Pharmacy is one of the largest 503A compounding pharmacies in Tennessee, located in Franklin, TN, and licensed to ship to 48 states. Specializes in bio-identical hormone replacement, topical pain management, scar therapy, pellet therapy, and sterile compounding. Named in a 2023 Novo Nordisk lawsuit over compounded semaglutide; the case was voluntarily dismissed.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Top-Rated GLP-1 Partners
Not sourced from DCA Pharmacy — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
No insurance needed · HSA/FSA eligible · vetted by our editors
Telos Rx
Needle-free, microdosed compounded GLP-1 with lab-monitored care
Starting price: $99/mo
Get started →Read review Telos Rx →RNK Health
Compounded GLP-1 alongside NAD+, peptide and longevity add-ons
Starting price: $197/mo
Get started →Read review RNK Health →Wellorithm
Compounded GLP-1 access with oral tablet options across 49 states
Starting price: $147/mo
Get started →Read review Wellorithm →| Provider | Starting price | |
|---|---|---|
7.4Telos Rx | $99/mo | Get started → |
8.1GobyMeds | $159/mo | Get started → |
7.6RNK Health | $197/mo | Get started → |
6.2Wellorithm | $147/mo | Get started → |
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (49)
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Medium confidence · Last verified 2026-05-23 via pharmacy-directory-cross-state-audit-2026-05-23 · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of August 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.